SOSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sosol, and what generic alternatives are available?
Sosol is a drug marketed by Mk Labs and is included in one NDA.
The generic ingredient in SOSOL is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
Summary for SOSOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Patent Applications: | 4,917 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SOSOL at DailyMed |
US Patents and Regulatory Information for SOSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mk Labs | SOSOL | sulfisoxazole | TABLET;ORAL | 080036-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |